Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release

被引:185
作者
Mattia, G [1 ]
Vulcano, F [1 ]
Milazzo, L [1 ]
Barca, A [1 ]
Macioce, G [1 ]
Giampaolo, A [1 ]
Hassan, HJ [1 ]
机构
[1] Ist Super Sanita, Dept Clin Biochem, I-00161 Rome, Italy
关键词
D O I
10.1182/blood.V99.3.888
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ploidy could be the key to understanding megakaryocyte (MK) biology and platelet production. Human CD34(+) cells purified from umbilical cord blood (CB) and peripheral blood (PB) were investigated on their capability to give rise, in a serum-free medium containing thrombopoietin, to MKs and platelets. CB-MKs showed reduced polyploidization and platelet number compared with PB-MKs, but a similar membrane phenotype. Most CB-MKs showed a 2N content of DNA (similar to80%) and only 2.6% had 8N, whereas 40% of the PB cells had 8N or more. Platelets were substantially released in PB culture from day 12; at day 14 the CB-derived MKs were able to release platelets although at a reduced level (similar to35%), correlating with their reduced size. A direct correlation was demonstrated by sorting polyploid cells from PB-MKs and evaluating the platelets released in the supernatant. Furthermore, the study analyzed the expression and distribution of cyclin D3 and cyclin B1. Cyclin D3 protein was increased in PB in comparison to CB-MKs; in PB culture most cells rapidly became positive, whereas in CB-derived cell cyclin D3 expression was evident only from day 9 and in a reduced percentage. Cyclin B1 was essentially localized at the nuclear level in the CB and was expressed during the whole culture. In PB-MKs, at day 9, a reduction was observed, correlating with an advanced ploidy state. The data indicate the inability of the CB-MKs to progress in the endomitotic process and a direct correlation between DNA content and platelet production. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:888 / 897
页数:10
相关论文
共 45 条
[1]  
ABGRALL JF, 1991, EXP HEMATOL, V19, P202
[2]   IDENTIFICATION AND CLONING OF A MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR THAT IS A LIGAND FOR THE CYTOKINE RECEPTOR MPL [J].
BARTLEY, TD ;
BOGENBERGER, J ;
HUNT, P ;
LI, YS ;
LU, HS ;
MARTIN, F ;
CHANG, MS ;
SAMAL, B ;
NICHOL, JL ;
SWIFT, S ;
JOHNSON, MJ ;
HSU, RY ;
PARKER, VP ;
SUGGS, S ;
SKRINE, JD ;
MEREWETHER, LA ;
CLOGSTON, C ;
HSU, E ;
HOKOM, MM ;
HORNKOHL, A ;
CHOI, E ;
PANGELINAN, M ;
SUN, Y ;
MAR, V ;
MCNINCH, J ;
SIMONET, L ;
JACOBSEN, F ;
XIE, C ;
SHUTTER, J ;
CHUTE, H ;
BASU, R ;
SELANDER, L ;
TROLLINGER, D ;
SIEU, L ;
PADILLA, D ;
TRAIL, G ;
ELLIOTT, G ;
IZUMI, R ;
COVEY, T ;
CROUSE, J ;
GARCIA, A ;
XU, W ;
DELCASTILLO, J ;
BIRON, J ;
COLE, S ;
HU, MCT ;
PACIFICI, R ;
PONTING, I ;
SARIS, C ;
WEN, D .
CELL, 1994, 77 (07) :1117-1124
[3]   Selective modulation of the cyclin B/CDK1 and cyclin D/CDK4 complexes during in vitro human megakaryocyte development [J].
Bassini, A ;
Pierpaoli, S ;
Falcieri, E ;
Vitale, M ;
Guidotti, L ;
Capitani, S ;
Zauli, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (04) :820-828
[4]   Kinetics of endomitosis in primary murine megakaryocytes [J].
Carow, CE ;
Fox, NE ;
Kaushansky, K .
JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 188 (03) :291-303
[5]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[6]  
CHOI ES, 1995, BLOOD, V85, P402
[7]   Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand [J].
Cramer, EM ;
Norol, F ;
Guichard, J ;
BretonGorius, J ;
Vainchenker, W ;
Masse, JM ;
Debili, N .
BLOOD, 1997, 89 (07) :2336-2346
[8]  
Darzynkiewicz Z, 1996, CYTOMETRY, V25, P1
[9]  
DEBILI N, 1991, BLOOD, V77, P2326
[10]  
DEBILI N, 1995, BLOOD, V86, P2516